Tuesday, February 23, 2021

Advertising

Home Business News Lineage to Present at the Raymond James 42nd Annual Institutional Investors Conference...

Lineage to Present at the Raymond James 42nd Annual Institutional Investors Conference on March 1, 2…


CARLSBAD, Calif.–()–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, Chief Executive Officer, will be presenting at the Raymond James 42nd Annual Institutional Investors conference on March 1, 2021 at 11:40am Eastern Time / 8:40am Pacific Time. Mr. Culley will also be presenting at the H.C. Wainwright Global Life Sciences Conference, being held virtually March 9-10, 2021.

Interested investors can access the live and archived webcasts on the Events and Presentations section of Lineage’s website. Additional videos are available on the Media page of the Lineage…



Click here to view the original article.

- Advertisment -
- Advertisment -

Recently Viewed

Harvey Norman Super Rugby AU Team of the Week for Round 1 – Rugby.com.au

Round one of Harvey Norman Super Rugby AU kicked off with a bang.

Teary-eyed Prince Charles leaves London hospital after visiting his father the Duke of Edinburgh – 7NEWS.com.au

The Prince of Wales was seen leaving the hospital where his father Prince Philip has been staying.

Prince William says Prince Philip is ‘OK’ as the Duke of Edinburgh spends a sixth night in hospital – ABC News

As Prince Philip spends a sixth night in hospital, his grandson Prince William gives an update on his condition and says doctors continue to "keep an eye" on him....

Black tie fundraiser the Great Humpty Ball to return next month

MAJOR Darwin event the Great Humpty Ball will return this year and is set to go ahead next month. Click here to view the...

You might also like ...

Cisco AppDynamics Launches New Research, Revealing Unprecedented Demand for Full-Stack Observability…
EnerBank Appoints Allyson Torsak as the Bank’s New Chief Strategy Officer